12:00 AM
Nov 24, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Cetuximab regulatory update

FDA's Oncologic Drugs Advisory Committee will meet on Dec. 16 to discuss BLAs for Erbitux cetuximab and Vectibix panitumumab in the context...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >